XML 17 R6.htm IDEA: XBRL DOCUMENT v3.20.4
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
6 Months Ended
Jan. 31, 2021
Jan. 31, 2020
CASH FLOWS FROM OPERATING ACTIVITIES    
Net (Loss) Income $ (35,395,697) $ (16,592,577)
Adjustments to reconcile net (loss) income to net cash used in operating activities:    
Depreciation and amortization 523,699 407,141
Amortization of operating lease right-of-use assets 36,581 45,128
Stock compensation expense 1,742,050 1,236,697
Shares issued for services 10,993 243,600
Loss of disposal of fixed assets 7,324 0
Amortization of debt discount 340,226 2,955,576
Change in fair value of derivative liabilities - convertible notes 100,177 (1,406,799)
Change in fair value of derivative liabilities - convertible warrants 11,137,037 51,823
Change in fair value of derivative liabilities - downside protection 0 5,000,966
Bad debt expense 0 10,981
Increase in notes payable due to default 255,080 0
Change in fair value of common stock payable (34,224) (115,054)
Changes in operating assets and liabilities, net of effect of acquisitions:    
Accounts receivable (4,620) (81,320)
Inventory 124,375 (232,015)
Accounts payable and accrued expenses 15,445,719 4,114,241
Interest payable to foundation 488,424 0
Contract liabilities 3,000,000 0
Operating lease liabilities (35,945) (44,338)
Other current assets (56,920) (216,352)
Other assets 0 2,183
Net cash used in operating activities (2,315,721) (4,620,119)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchase of property and equipment 0 (4,616)
Cash received in acquisition of a business, net of cash paid 0 49,305
Net cash provided by investing activities 0 44,689
CASH FLOWS FROM FINANCING ACTIVITIES    
Loan proceeds from related party 0 10,000
Payment of notes payable (127,459) (935,731)
Proceeds from note payable 0 5,361,975
Proceeds from issuance of common stock, net of fees of $20,376 and $0, respectively 1,164,616 109,770
Issuance of common stock in a private placement (PIPE), net of fees of $150,000 1,850,000 0
Proceeds from exercise of warrants 9,144 0
Net cash provided by financing activities 2,896,301 4,546,014
Net increase in cash and cash equivalents 580,580 (29,416)
Cash and cash equivalents, beginning of period 15,452 298,485
Cash and cash equivalents, end of period 596,032 269,069
Supplemental Disclosure of Cash Flow Information    
Cash paid for interest 50,000 25,000
Cash paid for taxes 0 0
Supplemental Disclosure of Non-Cash Investing and Financing Activities    
Reduction of derivative liabilities 537,936 2,276,078
Issuance of shares--common stock payable 1,472,826 921,895
Issuance of common stock for conversion of debt 1,127,842 2,904,695
Subscription receivable 0 765,970
Shares issued as debt issuance cost 0 141,990
Discount on derivative liability upon issuance of debt 0 1,574,685
Issuance of warrants from PIPE offering 21,574,216 0
Elimination of derivative liability from exercise of warrants $ 1,840,530 $ 0